BioVie Announces Data From Oral Bezisterim Presentation At Aging Research And Drug Discovery Meeting, Says 'Bezisterim Appears to Possess Broad Homeostatic Properties Relevant to Inflammation and Human Disorders Related to Aging'
BioVie Announces Data From Oral Bezisterim Presentation At Aging Research And Drug Discovery Meeting, Says 'Bezisterim Appears to Possess Broad Homeostatic Properties Relevant to Inflammation and Human Disorders Related to Aging'
BioVie宣佈口服Bezisterim在衰老研究與藥物發現會議上的數據，並表示'Bezisterim似乎具有與炎症和與衰老相關的人類疾病相關的廣泛穩態特性。
BioVie Announces Data From Oral Bezisterim Presentation At Aging Research And Drug Discovery Meeting, Says 'Bezisterim Appears to Possess Broad Homeostatic Properties Relevant to Inflammation and Human Disorders Related to Aging'
BioVie宣佈口服Bezisterim在衰老研究與藥物發現會議上的數據，並表示'Bezisterim似乎具有與炎症和與衰老相關的人類疾病相關的廣泛穩態特性。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。